Persistent expression of serum amyloid A during experimentally induced chronic inflammatory condition in rabbit involves differential activation of SAF, NF-κB, and C/EBP transcription factors

Journal of Immunology

Volumn 163, Issue 4, 1999, Pages 2143-2150

  Ray, Alpana ^a   Ray, Bimal K ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; SERUM AMYLOID A; TRANSCRIPTION FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION REGULATION; INFLAMMATORY DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; TRANSCRIPTION INITIATION;

ACUTE DISEASE; ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CHRONIC DISEASE; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); INFLAMMATION; INJECTIONS, SUBCUTANEOUS; NF-KAPPA B; NUCLEAR PROTEINS; ORGAN SPECIFICITY; RABBITS; SERUM AMYLOID A PROTEIN; SILVER NITRATE; TRANSCRIPTION FACTORS;

EID: 0033566744     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Benditt, E. P., and N. Eriksen. 1977. Amyloid protein SAA is associated with high density lipoprotein from human serum. Prof Natl. Acad. Sci. USA 74:4025.
2. Kushner, I. 1982. The phenomenon of acute phase response. Ann. NY Acad. Sci. 389:39.
3. Sipe, J. D. 1994. Amyloidosis. Cril. Rev. Clin. Lab. Sci. 31:325.
4. Mackiewicz, A., M. K. Ganapathi, D. Scultz, D. Samols, J. Reese, and I. Kushner. 1988. Regulation of rabbit acute phase protein biosynthesis by monokines. Biochem J. 253:351.
5. Kisilevsky, R. 1992. Serum amyloid A changes high density lipoprotein's cellular affinity: a clue to serum amyloid A's principal function. Lab. Invest. 66:778.
6. Benson, M. D., and M. Aldo-Benson. 1979. Effect of purified protein SAA on immune responses in vitro: mechanisms of suppression. J. Immunol. 122:2077.
7. Zimlichman, S., A. Danon, I. Nathan, G. Mozes, and R. Shainkin-Kestenbaum. 1990. Serum amyloid A, an acute phase protein, inhibits platelet activation. J. Lab. Clin. Med 116:180.
8. Linke, R. P., Bock, V., Valet, G., and Roth, G. 1991. Inhibition of oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid A protein. Biochem. Biophys. Res. Commun. 176:1100.
9. Betts, J. C., M. R. Edbrooke, R. V. Thakker, and P. Woo. 1991. The human acute-phase protein serum amyloid A gene family: structure, evolution, and expression in hepatoma cells. Scand. J. Immunol. 34:221.
10. Whitehead, A. S., M. C. deBeer, D. M. Steel, M. Rits, J. M. Lelias, W. S. Lane, and F. C. deBeer. 1992. Identification of novel members of the serum amyloid A protein super family as constitutive apolipoproteins of high density lipoprotein. J. Biol. Chem. 267:3862.
11. Kluve-Beckerman, B., M. L. Drumm, and M. D. Benson. 1991. Non-expression of the human serum amyloid A three (SAA3) gene. DNA Cell Biol. 10:651.
12. Sipe, J. D. 1999. Revised nomenclature for serum amyloid A (SAA). Amyloid Int. J. Exp. Clin. Invest. 6:67.
13. Lowell, C. A., D. A. Potter, R. S. Stearman, and J. F. Morrow. 1986. Structure of the murine serum amyloid A gene family. J. Biol. Chem. 261:8442.
14. Rygg, M., G. Marhaug, G. Husby, and S. B. Dowton. 1991. Rabbit serum amyloid protein A: expression and primary structure deduced from cDNA sequence. Scand. J. Immunol. 14:727.
15. Tatum, F., J. Alam, A. Smith, and W. T. Morgan. 1990. Molecular cloning, nucleotide sequence heterozygosily and regulation of serum amyloid A cDNA. Nucleic Acids Res. 18:7447.
16. Ray, B.K., and A. Ray. 1991. Complementary DNA cloning and nucleotide sequence of rabbit serum amyloid A protein. Biochem. Biophys. Res. Commun. 178:68.
17. Mitchell, T. I., C. I. Coon, and C. E. Brinckerhoff. 1991. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralized with specific antiserum. J. Clin. Invest. 87:1177.
18. Sano, K. 1988. Experimental amyloidosis induced by saponin. Acta Pathol. Jpn. 38:1241.
19. Ray, B. K., and A. Ray. 1991. Rabbit serum amyloid A gene: cloning, characterization, and sequence analysis. Biochem. Biophys. Res. Commun. 180:1258.
20. Glenner, G. G. 1980. Amyloid deposits and amyloidosis: the β fibrillosis. N. Engl. J. Med. 302:1283.
21. Benson, M. D., M. A. Scheinberg, T. Shirahama, E. S. Cathcart, and M. Skinner. 1977. Kinetics of serum amyloid A in casein-induced murine amyloidosis. J. Clin. Invest. 59:412.
22. Benson, M. D., and A. S. Cohen. 1979. Serum amyloid A protein in amyloidosis, rheumatic, and neoplastic diseases. Arthritis Rheum. 22:36.
23. deBeer, F. C., R. K. Mallya, E. A. Fagan, J. G. Lanham, G. R. V. Hughs, and M. B. Pepys. 1982. Serum amyloid A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet 2:231.
24. Loose, L. D., B. H. Littman, and J. D. Sipe. 1990. Inhibition of acute phase proteins by tenidap. Clin. Res. 38:A579.
25. 2-macroglobulin-like proteins. Science 243:655.
26. Meek, R.L., Urieli-Shovel, S., and E. P. Benditt. 1994. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc. Natl. Acad. Sci. USA 91:3186.
27. Liao, F., A. Andalibi, J. H. Qiao, H. Allayee, A. M. Fogelman, and A. J. Lusis. 1994. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J. Clin. Invest. 94:877.
28. Ray, B. K., S. Chatterjee, and A. Ray. 1999. Mechanism of MM-LDL mediated induction of serum amyloid A gene in monocyte/macrophage cells. DNA Cell Biol. 18:65.
29. Ray, A., and B. K. Ray. 1997. Serum amyloid A gene expression level in liver in response to different inflammatory agents is dependent upon the nature of activated transcription factors. DNA Cell Biol. 16:1.
30. Ray, A., and B. K. Ray. 1994. Serum amyloid A gene expression under acute-phase condition involves participation of inducible C/EBP-β and C/EBP-δ and their activation by protein phosphorylation. Mol. Cell. Biol. 14:4324.
31. Ray, B. K., and A. Ray. 1993 Functional NF-κB element in rabbit serum amyloid A gene and its role in acute phase induction. Biochem. Biophys. Res. Commun. 193:1159.
32. Ray, A., M. Hannink, and B. K. Ray. 1995. Concerted participation of NF-κB and C/EBP heteromer in lipopolysaccharide induction of serum amyloid A gene expression in liver. J. Biol. Chem. 270:7365.
33. Huang, J. H., and W. S. L. Liao 1994. Induction of mouse serum amyloid A3 gene by cytokines require both C/EBP family proteins and a novel constitutive nuclear factor. Mol. Cell. Biol. 14:4475.
34. Betts, J. C., J. K. Cheshire, S. Akira, T. Kishimoto, and P. Woo 1993. The role of NF-κB and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J. Biol. Chem. 268:25624.
35. Li, X., and W. S. L. Liao. 1991. Expression of rat serum amyloid A1 gene involves both C/EBP-like and NF-κB-like transcription factors. J. Biol. Chem. 266:15192.
36. Edbrooke, M. R., D. W. Burt, J. K. Cheshire, and P. Woo. 1989. Identification of cis-acting sequences responsible for phorbol ester induction of human serum amyloid A gene expression via a nuclear factor κB-like transcription factor. Mol. Cell. Biol. 9:1908.
37. Ray, A., and B. K. Ray. 1996. A novel cis-acting element is essential for cytokine mediated transcriptional induction of the serum amyloid A gene in nonhepatic cells. Mol. Cell. Biol. 16:1584.
38. Ray, B. K., and A. Ray. 1997. Involvement of an SAF-like transcription factor in the activation of serum amyloid A gene in monocyte/macrophage cells by lipopolysaccharide. Biochemistry 36:4662.
39. Ray, B. K., and A. Ray. 1997. Induction of serum amyloid A (SAA) gene by SAA-activating sequence-binding factor (SAF) in monocyte/macrophage cells. Evidence for a functional synergy between SAF and Sp1. J. Biol. Chem. 272: 28948.
40. Ray, A., and B. K. Ray. 1998. Isolation and functional characterization of cDNA of serum amyloid A-activating factor that binds to the serum amyloid A promoter. Mol. Cell. Biol. 18:7327.
41. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acidic guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
42. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
43. Pepys, M. B. 1981. Serum C-reactive protein, serum amyloid P component and serum amyloid A protein in autoimmune disease. Clin. Immunol. Allergy 1981:77.
44. Zabel, U., and P. A. Baeuerle. 1990. Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell 65: 225.
45. Wulczyn, F. G., M. Neumann, and C. Scheidereit. 1992. Candidate proto-oncogene bcl-3 encodes a subunit specific inhibitor of transcription factor NF-κB. Nature 358:597.
46. Bitko, V., and S. Barik. 1998. Persistent activation of RelA by respiratory syncytial virus involves protein kinase C, underphosphorylated IκBβ, and sequestration of protein phosphatase 2A by the viral phosphoprotein. J. Virol. 72:5610.
47. Cooper, C., A. Henderson, S. Artandi, N. Avitahl, and K. Calame. 1995. Ig/EBP (C/EBP-γ) is a transdominant negative inhibitor of C/EBP family transcriptional activators. Nucleic Acids Res. 23:4371.
48. Decombes, P., and U. Scheibler. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67:569.
49. Ron, D., and J. F. Habener. 1992. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant negative inhibitor of gene transcription. Genes Dev. 6:439.
50. Flemming, J. V., S. M. Hay, D. N. Harries, and W. D. Rees. 1998. Effects of nutrient deprivation and differentiation on the expression of growth arrest genes (gas and gadd) in F9 embryonal carcinoma cells. Biochem J. 330:573.